Biologics in Allergic/Immunologic Conditions, An Issue of Immunology and Allergy Clinics of North America
- 1st Edition, Volume 44-4 - October 24, 2024
- Latest edition
- Editor: Flavia Hoyte
- Language: English
In this issue of Immunology and Allergy Clinics, guest editor Dr. Flavia Hoyte brings her considerable expertise to the topic of Biologics in Allergic/Immunologic Condition… Read more
Purchase options
In this issue of Immunology and Allergy Clinics, guest editor Dr. Flavia Hoyte brings her considerable expertise to the topic of Biologics in Allergic/Immunologic Conditions. Top experts provide an overview of the state of biologic treatments for autoimmune and allergic conditions including asthma, COPD, food allergies, atopic dermatitis; and more.
- Contains 13 relevant, practice-oriented topics including current and emerging biologics in CSU; biologics in AERD and ABPA; and multiple articles on biologics in asthma, including the role of biomarkers, the potential to achieve clinical remission, real-world studies, emerging biologics; and more.
- Provides in-depth clinical reviews on biologics in allergic/immunologic conditions, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Allergists
Current and Emerging Biologics for Atopic Dermatitis
Chronic Spontaneous Urticaria: Current and Emerging Biologic Agents
Advancements in Biologic Therapies for Eosinophilic Gastrointestinal Diseases: A Comprehensive Review
Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis
Biologics in Food Allergies: Emerging Therapies
Biologics in Chronic Rhinosinusitis: Current and Emerging
Biologics in Aspirin-Exacerbated Respiratory Disease and Allergic Bronchopulmonary Aspergillosis
Asthma Biologics: Lung Function, Steroid-Dependence, and Exacerbations
Biologics in Asthma: Role of Biomarkers
Biologics in Asthma: Potential to Achieve Clinical Remission
Real-World Studies of Biologics for the Treatment of Moderate-to-Severe Asthma
Biologics in Asthma: Emerging Biologics
Chronic Spontaneous Urticaria: Current and Emerging Biologic Agents
Advancements in Biologic Therapies for Eosinophilic Gastrointestinal Diseases: A Comprehensive Review
Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis
Biologics in Food Allergies: Emerging Therapies
Biologics in Chronic Rhinosinusitis: Current and Emerging
Biologics in Aspirin-Exacerbated Respiratory Disease and Allergic Bronchopulmonary Aspergillosis
Asthma Biologics: Lung Function, Steroid-Dependence, and Exacerbations
Biologics in Asthma: Role of Biomarkers
Biologics in Asthma: Potential to Achieve Clinical Remission
Real-World Studies of Biologics for the Treatment of Moderate-to-Severe Asthma
Biologics in Asthma: Emerging Biologics
- Edition: 1
- Latest edition
- Volume: 44-4
- Published: October 24, 2024
- Language: English
FH
Flavia Hoyte
Affiliations and expertise
Allergist and Immunologist, National Jewish Health, Division of Allergy and Clinical Immunology, Denver Colorado